<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-057798</identifier>
<setSpec>1130-6343</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">Objective: To study the impact of depressive disorders (DD) on        health care expenditure and to measure associated comorbidity in        patients in primary care settings (PCS) under normal clinical practice        conditions.        Method: A retrospective cohort study was carried out. The        study cohort consisted of outpatients aged over 14 years of age with        an established diagnosis of DD (ICPC; P76) treated in a PC health        centre during 2004. A comparative cohort was formed with the        remaining outpatients without DD, treated in that health centre.        Main factors for calculation were: age, gender, history/comorbidity        and health resource use and the corresponding outpatient costs;        drugs, diagnostic tests, visits to specialists and PC physicians. Multiple        logistic regression analysis and ANCOVA models were used in        order to adjust costs and comorbidities between the cohorts of        patients.        Results: A total of 64,072 subjects were assessed; 6,592        patients with DD [10.3% (CI: 8.2-12.4%), 74.5% (CI: 73.4%-        75.6%) females]. DD outpatients displayed a higher number of        episodes of comorbidities/year (mean ± SD; 7.4 ± 4.3 vs. 4.7 ±        3.3, p &lt; 0.0001) and global medical visits/patient/year (12.0 ±        9.3 vs. 7.4 ± 7.6, p &lt; 0.0001). The main comorbidities associated        to DD were neurological disorders [Odds ratio (95% CI); 2.1        (CI: 1.5-2.6), p &lt; 0.0001], alcoholism [1.6 (CI: 1.3-1.9), p &lt;        0.0001] and malignancies [1.3 (CI: 1.1-1.5), p &lt; 0.0001]. DD        were associated with significantly higher adjusted total costs;        &#128; 1,083.8 (SEM; &#128; 8.4) vs. &#128; 684.1 (&#128; 3.4), p &lt; 0.0001. Higher        costs were displayed for elderly patients. Sixty-two percent of        the total cost was related to drugs.        Conclusions: Prevalence of DD was higher, particularly in        women. Following adjustment in accordance with comorbidity,        age and sex, DD outpatients used more health care resources and        implied higher costs. Higher costs were associated with age</dc:description>
<dc:creator>Serrat Tarrés, J</dc:creator>
<dc:creator>Llopart López, J. R</dc:creator>
<dc:creator>Navarro Artieda, R</dc:creator>
<dc:creator>Rejas Gutiérrez, J</dc:creator>
<dc:creator>Blanca Tamayo, M</dc:creator>
<dc:creator>Sicras Mainar, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Medir el impacto económico de los trastornos        depresivos (TD) y la comorbilidad asociada en en población atendida        por equipos de atención primaria (EAP) en condiciones de        práctica clínica habitual.        Método: Estudio de cohortes retrospectivo. Se incluyeron        pacientes mayores de 14 años, con diagnóstico de TD (CIAP;        P76) atendidos por EAP durante el año 2004. Se formó una        cohorte comparativa con el resto de pacientes sin TD. Las variables        fueron: edad, sexo, historial/comorbilidad, utilización de recursos        sanitarios y costes correspondientes (medicamentos, procedimientos        diagnósticos, visistas a especialistas y a EAP). Se efectuó un        análisis de regresión logística múltiple y modelos ANCOVA para        comparar los costes, totales y desagregados, y las comorbilidades.        Resultados: Se incluyeron 64.072 pacientes; 6.592 con TD        [10,3% (CI: 8,2-12,4%); 7,5% (CI: 73,4-756%) mujeres]. Los        pacientes con TD presentaron un mayor número de episodios de        comorbilidades/año (media ± DE; 7,4 ± 4,3 vs. 4,7 ± 3,3; p &lt;        0,0001) y de todo tipo de visitas médicas/paciente/año (12,0 ±        9,3 vs. 7,4 ± 7,6; &lt; 0,0001). Las principales episodios de comorbilidad        asociados con los TD fueron los trastornos neurológicos        [Odd ratio (IC 95%); 2,1 (1,5-2,6); p &lt; 0,0001], alcoholismo [1,6        (1,3-1,9), p &lt; 0,0001] y neoplasias malignas [1,3 (1,1-1,5); p &lt;        0,0001]. Los TD se asociaron con unos costes totales ajustados        significativamente mayores; 1.083,8 (EEM; 8,4 ) vs. 684,1        (3,4 ); p &lt; 0,0001. Las personas mayores mostraron mayores        costes. El 62% de los costes totales se derivó de los medicamentos.        Conclusiones: La prevalencia de los TD es elevada, particularmente        en mujeres. Después del ajuste por comorbilidad, edad y        sexo, los pacientes con TD utilizaron más recursos sanitarios y        ocasionaron unos costes más altos. Los costes más elevados se        asociaron con la edad</dc:description>
<dc:source>Farm Hosp;31(2): 101-105, mar.-abr.2007. tab</dc:source>
<dc:identifier>ibc-057798</dc:identifier>
<dc:title xml:lang="es">Comorbilidad y coste ambulatorio asociado a los pacientes con trastornos depresivos en un ámbito poblacional</dc:title>
<dc:subject>^d28621</dc:subject>
<dc:subject>^d3886^s22018</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d440^s22012</dc:subject>
<dc:subject>^d29362</dc:subject>
<dc:subject>^d3886^s22057</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d24572</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d9615^s22012</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d30057</dc:subject>
<dc:subject>^d556^s22018</dc:subject>
<dc:subject>^d555^s22018</dc:subject>
<dc:type>article</dc:type>
<dc:date>200704</dc:date>
</metadata>
</record>
</ibecs-document>
